Truist Financial Corp Humacyte, Inc. Transaction History
Truist Financial Corp
- $71.8 Billion
- Q3 2025
A detailed history of Truist Financial Corp transactions in Humacyte, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 16,282 shares of HUMA stock, worth $20,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,282Holding current value
$20,515% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
164Shares Held
50.8MCall Options Held
1.1MPut Options Held
808K-
Vanguard Group Inc Valley Forge, PA7.52MShares$9.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$5.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$3.72 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.64MShares$3.33 Million0.01% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $130M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...